ArticleCancers2022

Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma.

Antonella Ravaggi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.